Gamma Investing LLC Harrow Health, Inc. Transaction History
Gamma Investing LLC
- $1.58 Trillion
- Q2 2025
A detailed history of Gamma Investing LLC transactions in Harrow Health, Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 334 shares of HROW stock, worth $11,633. This represents 0.0% of its overall portfolio holdings.
Number of Shares
334
Previous 236
41.53%
Holding current value
$11,633
Previous $6.28 Million
62.47%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding HROW
# of Institutions
175Shares Held
21.5MCall Options Held
390KPut Options Held
413K-
Opaleye Management Inc. Boston, MA3.91MShares$136 Million28.52% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$74.8 Million0.0% of portfolio
-
Private Capital Management, LLC Naples, FL1.95MShares$67.8 Million6.93% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$65.1 Million0.0% of portfolio
-
Braidwell LP Stamford, CT872KShares$30.4 Million1.63% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $943M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...